Skye Bioscience Inc (SKYE)
12.64
-0.29
(-2.24%)
USD |
NASDAQ |
May 01, 16:00
12.64
0.00 (0.00%)
After-Hours: 20:00
Skye Bioscience Enterprise Value: 365.97M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 365.97M |
| April 29, 2024 | 367.93M |
| April 26, 2024 | 367.93M |
| April 25, 2024 | 363.72M |
| April 24, 2024 | 363.72M |
| April 23, 2024 | 396.84M |
| April 22, 2024 | 418.73M |
| April 19, 2024 | 456.05M |
| April 18, 2024 | 479.34M |
| April 17, 2024 | 490.29M |
| April 16, 2024 | 459.14M |
| April 15, 2024 | 367.93M |
| April 12, 2024 | 365.41M |
| April 11, 2024 | 359.23M |
| April 10, 2024 | 362.60M |
| April 09, 2024 | 260.45M |
| April 08, 2024 | 272.24M |
| April 05, 2024 | 257.08M |
| April 04, 2024 | 314.05M |
| April 03, 2024 | 378.88M |
| April 02, 2024 | 398.80M |
| April 01, 2024 | 401.05M |
| March 28, 2024 | 442.02M |
| March 27, 2024 | 405.54M |
| March 26, 2024 | 389.54M |
| Date | Value |
|---|---|
| March 25, 2024 | 379.16M |
| March 22, 2024 | 339.87M |
| March 21, 2024 | 365.13M |
| March 20, 2024 | 358.25M |
| March 19, 2024 | 169.83M |
| March 18, 2024 | 169.83M |
| March 15, 2024 | 166.25M |
| March 14, 2024 | 162.42M |
| March 13, 2024 | 133.40M |
| March 12, 2024 | 132.16M |
| March 11, 2024 | 126.61M |
| March 08, 2024 | 167.67M |
| March 07, 2024 | 176.00M |
| March 06, 2024 | 210.58M |
| March 05, 2024 | 222.31M |
| March 04, 2024 | 225.40M |
| March 01, 2024 | 209.72M |
| February 29, 2024 | 182.92M |
| February 28, 2024 | 163.66M |
| February 27, 2024 | 182.18M |
| February 26, 2024 | 104.32M |
| February 23, 2024 | 92.03M |
| February 22, 2024 | 87.09M |
| February 21, 2024 | 80.30M |
| February 20, 2024 | 76.84M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.584M
Minimum
Dec 11 2020
490.29M
Maximum
Apr 17 2024
36.99M
Average
21.20M
Median
Enterprise Value Benchmarks
| Cutera Inc | 323.39M |
| Medical Marijuana Inc | 11.88M |
| OrthoPediatrics Corp | 634.54M |
| RAPT Therapeutics Inc | 109.08M |
| NovaBay Pharmaceuticals Inc | 2.389M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.420M |
| Total Expenses (Quarterly) | 4.086M |
| EPS Diluted (Quarterly) | -0.3579 |
| Earnings Yield | -54.02% |
| Normalized Earnings Yield | -3.713 |